Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan. [electronic resource]
Producer: 20190314Description: 815-820 p. digitalISSN:- 1532-8511
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antithrombins -- administration & dosage
- Atrial Fibrillation -- blood
- Blood Coagulation -- drug effects
- Cerebral Hemorrhage -- chemically induced
- Dabigatran -- administration & dosage
- Drug Administration Schedule
- Feasibility Studies
- Female
- Fibrinolytic Agents -- administration & dosage
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Retrospective Studies
- Risk Factors
- Stroke -- blood
- Taiwan -- epidemiology
- Thrombolytic Therapy -- adverse effects
- Time Factors
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.